3D Pharmacophore models are three-dimensional ensembles of chemically specified interactions of a ligand in its bioactive state. They are now an important technique in drug design because they offer a sophisticated method of deciphering chemically stored ligand information. The important research for using 3D pharmacophore models in high - throughput screening and mechanistic investigations for protein functioning are summarised in this review, along with an outline of the method's fundamental principles. We also go over current advancements in the area. Since these methods take into account macromolecule-ligand interactions as dynamic and hence display an interaction pattern that is physiologically accurate, combining 3D pharmacophore models with molecular dynamics simulations might be a huge step forward. The effective use of 3D pharmacophore data in artificial intelligence and machine learning is another trend. Other themes include using 3D pharmacophore data effectively in machine learning and artificial intelligence applications or providing 3D pharmacophore modelling on publicly available web servers. Recent advancements demonstrate that 3D pharmacophore modelling is a dynamic area with many implications in drug discovery and beyond.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico